BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36326317)

  • 41. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
    Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
    Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
    Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-Dose Naltrexone in Endometrial Intraepithelial Neoplasia.
    McKenzie-Brown AM; Khanna N; Singh V
    Pain Med; 2022 Apr; 23(4):866-868. PubMed ID: 34240210
    [No Abstract]   [Full Text] [Related]  

  • 44. Computational augmentation of neoplastic endometrial glands in digital pathology displays.
    Papke DJ; Lohmann S; Downing M; Hufnagl P; Mutter GL
    J Pathol; 2021 Mar; 253(3):258-267. PubMed ID: 33165914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of hysteroscopy during conservative management of atypical endometrial hyperplasia and early-stage endometrial cancer in patients who desire pregnancy.
    Gil González Y; Pérez Morales ME; Emergi Zhrigen Y; Santana Suárez MA; Pérez Matos C; Nieto Naya MÁ; Ocón Padrón L; Laseca Modrego M; Arencibia Sánchez O; Sánchez Sánchez V; Martín Martínez AI
    J Obstet Gynaecol; 2022 Nov; 42(8):3435-3440. PubMed ID: 37017372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management.
    Vaugon M; Peigné M; Phelippeau J; Gonthier C; Koskas M
    Reprod Biomed Online; 2021 Sep; 43(3):495-502. PubMed ID: 34315696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of endometrial intraepithelial neoplasia with WHO endometrial hyperplasia classification system. A comparative study of 150 cases.
    Popat VC; Vora DN; Gadhvi NS; Bhanvadia VM; Madan YG
    Histopathology; 2010 Oct; 57(4):646-8. PubMed ID: 20955392
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of endometrial precancers.
    Trimble CL; Method M; Leitao M; Lu K; Ioffe O; Hampton M; Higgins R; Zaino R; Mutter GL;
    Obstet Gynecol; 2012 Nov; 120(5):1160-75. PubMed ID: 23090535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network.
    Zhao F; Dong D; Du H; Guo Y; Su X; Wang Z; Xie X; Wang M; Zhang H; Cao X; He X
    Comput Methods Programs Biomed; 2022 Jun; 221():106906. PubMed ID: 35671602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia.
    Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH
    Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms.
    Clarke MA; Long BJ; Sherman ME; Lemens MA; Podratz KC; Hopkins MR; Ahlberg LJ; Mc Guire LJ; Laughlin-Tommaso SK; Bakkum-Gamez JN; Wentzensen N
    Am J Obstet Gynecol; 2020 Oct; 223(4):549.e1-549.e13. PubMed ID: 32268124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/endometrial cancer: Wait or treat!
    Bostancı Eİ; Durmuş Y; Çöteli ASD; Kayakçıoğlu F; Boran N
    Turk J Med Sci; 2022 Jun; 52(3):871. PubMed ID: 36326326
    [No Abstract]   [Full Text] [Related]  

  • 54. Molecular biomarkers in endometrial hyperplasias predict cancer progression.
    Steinbakk A; Gudlaugsson E; Aasprong OG; Skaland I; Malpica A; Feng W; Janssen EA; Baak JP
    Am J Obstet Gynecol; 2011 Apr; 204(4):357.e1-12. PubMed ID: 21324435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification.
    Ordi J; Bergeron C; Hardisson D; McCluggage WG; Hollema H; Felix A; Soslow RA; Oliva E; Tavassoli FA; Alvarado-Cabrero I; Wells M; Nogales FF
    Histopathology; 2014 Jan; 64(2):284-92. PubMed ID: 24111732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
    Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
    Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma.
    Chapel DB; Patil SA; Plagov A; Puranik R; Mendybaeva A; Steinhardt G; Wanjari P; Lastra RR; Kadri S; Segal JP; Ritterhouse LL
    Mod Pathol; 2019 Oct; 32(10):1508-1520. PubMed ID: 31186530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endometrial intraepithelial neoplasia with secretory differentiation: diagnostic features and underlying mechanisms.
    Parra-Herran CE; Monte NM; Mutter GL
    Mod Pathol; 2013 Jun; 26(6):868-73. PubMed ID: 23328979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Precursor lesions of endometrial carcinoma].
    Lax SF
    Pathologe; 2019 Feb; 40(1):13-20. PubMed ID: 30707274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia.
    Marnach ML; Butler KA; Henry MR; Hutz CE; Langstraat CL; Lohse CM; Casey PM
    J Womens Health (Larchmt); 2017 Apr; 26(4):368-373. PubMed ID: 27901412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.